First Time Loading...
B

Biohit Oyj
OMXH:BIOBV

Watchlist Manager
Biohit Oyj
OMXH:BIOBV
Watchlist
Price: 2.01 EUR Market Closed
Updated: May 19, 2024
Section:
 

Relative Value

The Relative Value of one BIOBV stock under the Base Case scenario is 2.91 EUR. Compared to the current market price of 2.01 EUR, Biohit Oyj is Undervalued by 31%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BIOBV Relative Value
Base Case
2.91 EUR
Undervaluation 31%
Relative Value
Price
B
Worst Case
Base Case
Best Case

Valuation Multiples

2.3
P/S
P/S
Price to Sales
2.3
vs History
79
vs Industry
47
Median 3Y
2.5
Median 5Y
3.5
Industry
2.4
Forward
2
More Details
16.4
P/E
P/E
Price to Earnings
16.4
vs History
28
vs Industry
33
Median 3Y
16.4
Median 5Y
-10.1
Industry
24.1
Forward
15
More Details
33.7
P/OCF
P/OCF
Price to OCF
33.7
vs History
19
vs Industry
12
Median 3Y
15.1
Median 5Y
-51.9
Industry
16
More Details
367.9
P/FCFE
P/FCFE
Price to FCFE
367.9
vs History
0
vs Industry
1
Median 3Y
-29.8
Median 5Y
-76.7
Industry
23.1
More Details
3.2
P/B
P/B
Price to Book Value
3.2
vs History
49
vs Industry
28
Median 3Y
3.4
Median 5Y
3.2
Industry
2.3
More Details
1.8
EV/S
EV/S
Enterprise Value to Sales
1.8
vs History
76
vs Industry
52
Median 3Y
2
Median 5Y
2.6
Industry
2.5
Forward
1.6
More Details
2.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.8
vs History
74
vs Industry
63
Median 3Y
3.1
Median 5Y
3.8
Industry
5.3
More Details
11
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
11
vs History
38
vs Industry
31
Median 3Y
11
Median 5Y
8.2
Industry
13.1
Forward
11.7
More Details
13.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
13.2
vs History
25
vs Industry
34
Median 3Y
12.7
Median 5Y
-8.6
Industry
17.8
Forward
11.7
More Details
26.6
EV/OCF
EV/OCF
Enterprise Value to OCF
26.6
vs History
19
vs Industry
16
Median 3Y
12
Median 5Y
-39.8
Industry
15.5
More Details
36.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
36.7
vs History
19
vs Industry
14
Median 3Y
12.4
Median 5Y
-37
Industry
19.7
More Details
4.2
EV/IC
EV/IC
Enterprise Value to IC
4.2
vs History
57
vs Industry
21
Median 3Y
4.6
Median 5Y
4.5
Industry
2
More Details

Multiples Across Competitors

BIOBV Competitors Multiples
Biohit Oyj Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FI
Biohit Oyj
OMXH:BIOBV
30.4m EUR 2.3 16.4 11 13.2
US
Abbott Laboratories
NYSE:ABT
181.1B USD 4.5 32.2 19 28.3
US
Intuitive Surgical Inc
NASDAQ:ISRG
141.5B USD 19.3 71.2 58.5 73.3
US
Stryker Corp
NYSE:SYK
127.5B USD 6.1 37.9 24.6 30.3
IE
Medtronic PLC
NYSE:MDT
114.2B USD 3.5 27.2 14.4 20.3
US
Boston Scientific Corp
NYSE:BSX
109.7B USD 7.5 62.1 31.2 46.2
US
Becton Dickinson and Co
NYSE:BDX
68.6B USD 3.5 52.1 18.2 37.1
DE
Siemens Healthineers AG
XETRA:SHL
59.2B EUR 2.7 32.2 18.2 27
US
Edwards Lifesciences Corp
NYSE:EW
53.7B USD 8.7 38 27.6 29.9
US
Dexcom Inc
NASDAQ:DXCM
52B USD 13.7 81.4 60.8 79.2
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
373.7B CNY 10.4 30.7 28.3 28.3

See Also

Summary
BIOBV intrinsic value, competitors valuation, and company profile.
DCF Valuation
BIOBV stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BIOBV stock valuation using valuation multiples.
Wall Street Estimates
BIOBV price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BIOBV stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.